Statistics for Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022
Total visits
views | |
---|---|
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022 | 2 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
java.util.UUID:49509352-e0bc-425c-98f7-18b68ec83f2c | 26 |
java.util.UUID:b6825627-5e50-4b7c-9c3f-6fa92aefa4d6 | 16 |
java.util.UUID:fa78ea0d-ec5d-418b-9536-b553c697f163 | 9 |
Top country views
views | |
---|---|
United States | 2 |
Top city views
views | |
---|---|
Indianapolis | 2 |